Education
About Us
Working with TipRanks
Follow Us
Ondine Biomedical, Inc. (GB:OBI)
LSE:OBI
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | C$ 2.05M | C$ 1.20M | C$ 638.00K | C$ 2.57M | C$ 1.79M |
| Gross Profit | C$ 1.32M | C$ 703.00K | C$ 287.00K | C$ 1.25M | C$ 649.00K |
| Operating Income | C$ -19.44M | C$ -14.80M | C$ -18.76M | C$ -17.52M | C$ -15.87M |
| EBITDA | C$ -18.49M | C$ -13.79M | C$ -18.85M | C$ -48.36M | C$ -14.56M |
| Net Income | C$ -19.10M | C$ -14.41M | C$ -19.37M | C$ -50.09M | C$ -16.27M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | C$ 9.77M | C$ 2.98M | C$ 13.13M | C$ 30.36M | C$ 626.00K |
| Total Assets | C$ 12.82M | C$ 5.73M | C$ 16.57M | C$ 34.14M | C$ 2.63M |
| Total Debt | C$ 168.00K | C$ 541.00K | C$ 896.00K | C$ 739.00K | C$ 31.46M |
| Net Debt | C$ -9.60M | C$ -2.44M | C$ -12.23M | C$ -29.63M | C$ 30.83M |
| Total Liabilities | C$ 5.95M | C$ 3.65M | C$ 4.92M | C$ 4.48M | C$ 36.46M |
| Stockholders' Equity | C$ 6.88M | C$ 2.08M | C$ 11.64M | C$ 29.66M | C$ -33.81M |
| Cash Flow | |||||
| Free Cash Flow | C$ -15.50M | C$ -13.83M | C$ -16.66M | C$ -12.62M | C$ -6.43M |
| Operating Cash Flow | C$ -15.49M | C$ -13.65M | C$ -16.34M | C$ -12.54M | C$ -6.33M |
| Investing Cash Flow | C$ -10.00K | C$ -177.00K | C$ -311.00K | C$ -77.00K | C$ 2.90M |
| Financing Cash Flow | C$ 21.74M | C$ 3.79M | C$ -275.00K | C$ 41.90M | C$ 3.83M |
Ondine Biomedical, Inc. Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.